UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Vascular medicine (London, England), 2020-04, Vol.25 (2), p.103-105

Hiatt, William R

2020

Volltextzugriff (PDF)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Vascular medicine (London, England), 2015-10, Vol.20 (5), p.465-478

2015

Volltextzugriff (PDF)

Lost in translation: Why ‘lost to follow-up’ matters

Vascular medicine (London, England), 2019-08, Vol.24 (4), p.339-340

2019

Volltextzugriff (PDF)

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial

Vascular medicine (London, England), 2018-12, Vol.23 (6), p.523-530

2018

Volltextzugriff (PDF)

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial

Vascular medicine (London, England), 2022-02, Vol.27 (1), p.21-29

2022

Volltextzugriff (PDF)

A systematic review and meta-analysis of propionyl-l-carnitine effects on exercise performance in patients with claudication

Vascular medicine (London, England), 2013-02, Vol.18 (1), p.3-12

2013

Volltextzugriff (PDF)

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

Vascular medicine (London, England), 2014-12, Vol.19 (6), p.473-482

2014

Volltextzugriff (PDF)

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial

Vascular medicine (London, England), 2019-10, Vol.24 (5), p.422-430

2019

Volltextzugriff (PDF)

Prognostic value of an increase in post-exercise ankle-brachial index

Vascular medicine (London, England), 2017-06, Vol.22 (3), p.204-209

2017

Volltextzugriff (PDF)

Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial

Vascular medicine (London, England), 2021-12, Vol.26 (6), p.608-612

2021

Volltextzugriff (PDF)

Community-based walking exercise for peripheral artery disease: An exploratory pilot study

Vascular medicine (London, England), 2015-08, Vol.20 (4), p.339-347

2015

Volltextzugriff (PDF)

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: Safety, walking distance and endothelial function

Vascular medicine (London, England), 2014-02, Vol.19 (1), p.9-17

2014

Volltextzugriff (PDF)

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution

Vascular medicine (London, England), 2018-12, Vol.23 (6), p.513-522

2018

Volltextzugriff (PDF)

Progression of asymptomatic peripheral artery disease over 1 year

Vascular medicine (London, England), 2012-02, Vol.17 (1), p.10-16

2012

Volltextzugriff (PDF)

A validated biomarker panel to identify peripheral artery disease

Vascular medicine (London, England), 2012-12, Vol.17 (6), p.386-393

2012

Volltextzugriff (PDF)

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease

Vascular medicine (London, England), 2014-08, Vol.19 (4), p.297-306

2014

Volltextzugriff (PDF)

The Society for Vascular Medicine: The first quarter century

Vascular medicine (London, England), 2015-02, Vol.20 (1), p.60-68

2015

Volltextzugriff (PDF)

Why TASC II?

Vascular medicine (London, England), 2007-11, Vol.12 (4), p.327-327

2007

Volltextzugriff (PDF)

The effects of vascular disease and aging on the regulation of circulating endothelial progenitor cells

Vascular medicine (London, England), 2006-11, Vol.11 (4), p.258-258

Hiatt, William R

2006

Volltextzugriff (PDF)

Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication

Vascular medicine (London, England), 2001-11, Vol.6 (4), p.235-239

2001

Volltextzugriff (PDF)

Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y 12 inhibitors: Insights from the EUCLID trial

Vascular medicine (London, England), 2021-12, Vol.26 (6), p.608-612

2021

Volltextzugriff (PDF)

Current and Future Drug Therapies for Claudication

Vascular medicine (London, England), 1997-08, Vol.2 (3), p.257-262

Hiatt, William R

1997

Volltextzugriff (PDF)

PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS program

Vascular medicine (London, England), 2001-02, Vol.6 (1_suppl), p.9-12

2001

Volltextzugriff (PDF)

Exercise Testing and Exercise Rehabilitation for Patients with Peripheral Arterial Disease: Status in 1997

Vascular medicine (London, England), 1997-05, Vol.2 (2), p.147-155

1997

Volltextzugriff (PDF)

Negative impact of cardiac evaluation before vascular surgery

Vascular medicine (London, England), 2000-02, Vol.5 (1), p.3-9

2000

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaBlood And Lymphatic Vessels

Zeitschrift / SerieVascular Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Cardiovascular System & Cardiology
(22)
Life Sciences & Biomedicine
(22)
Peripheral Vascular Disease
(22)
Science & Technology
(22)
Humans
(21)
Peripheral Artery Disease
(14)
Male
(10)
Risk Factors
(10)
Aged
(9)
Middle Aged
(9)
Claudication
(8)
Female
(8)
Treatment Outcome
(8)
Cardiovascular Diseases
(7)
Aged, 80 And Over
(6)
Exercise Test
(6)
Intermittent Claudication - Drug Therapy
(6)
Patients
(6)
Vascular Diseases
(6)
Clopidogrel
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Vascular Medicine Review
(1)

Menü

Weitere Dienste

Einstellungen

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Lost in translation: Why ‘lost to follow-up’ matters

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial

A systematic review and meta-analysis of propionyl-l-carnitine effects on exercise performance in patients with claudication

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial

Prognostic value of an increase in post-exercise ankle-brachial index

Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial

Community-based walking exercise for peripheral artery disease: An exploratory pilot study

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: Safety, walking distance and endothelial function

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution

Progression of asymptomatic peripheral artery disease over 1 year

A validated biomarker panel to identify peripheral artery disease

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease

The Society for Vascular Medicine: The first quarter century

Why TASC II?

The effects of vascular disease and aging on the regulation of circulating endothelial progenitor cells

Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication

Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y 12 inhibitors: Insights from the EUCLID trial

Current and Future Drug Therapies for Claudication

PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS program

Exercise Testing and Exercise Rehabilitation for Patients with Peripheral Arterial Disease: Status in 1997

Negative impact of cardiac evaluation before vascular surgery

Aktive Filter

Suchergebnisse filtern